Venture capital financing for UK life sciences start-ups soars

Total venture capital funding attracted by the UK life sciences industry rose by 41% last year, to $713m, with two companies developing therapies to boost human beings’ immune response to diseases accounting for the three biggest financing rounds.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump